Matthew C. Abernethy
2019
Compensation breakdown
| Bonus | $284,970 |
|---|---|
| Option Awards | $3,750,345 |
| Salary | $495,600 |
| Stock Awards | $1,250,035 |
| Other | $42,170 |
| Total | $5,823,120 |
Abernethy received $3.8M in option awards, accounting for 64% of the total pay in 2019.
Abernethy also received $285K in bonus, $495.6K in salary, $1.3M in stock awards and $42.2K in other compensation.
Rankings
In 2019, Matthew C. Abernethy's compensation ranked 1,788th out of 13,971 executives tracked by ExecPay. In other words, Abernethy earned more than 87.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,788 out of 13,971 | 87th |
Division Manufacturing | 638 out of 5,701 | 89th |
Major group Chemicals And Allied Products | 193 out of 2,200 | 91st |
Industry group Drugs | 155 out of 1,886 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 36 out of 389 | 91st |
Pay ratio
| Matthew C. Abernethy's Pay | $5,823,120 |
|---|---|
| Median Employee's Pay | $257,209 |
| Pay Ratio | 23to 1 |
In 2019, the annual total compensation of Matthew C. Abernethy was $5,823,120.
The annual total compensation of the median employee at Neurocrine Biosciences was $257,209.
The ratio of Matthew C. Abernethy's pay to the pay of median employee was therefore 23 to one.
Abernethy's colleagues
We found five more compensation records of executives who worked with Matthew C. Abernethy at Neurocrine Biosciences in 2019.
2019
Kevin Gorman
Neurocrine Biosciences
Chief Executive Officer
2019
Eric Benevich
Neurocrine Biosciences
Chief Commercial Officer
2019
Eiry Roberts
Neurocrine Biosciences
Chief Medical Officer
2019
Haig Bozigian
Neurocrine Biosciences
Chief Development Officer
2019
Kyle Gano
Neurocrine Biosciences
Chief Development and Strategy Officer
News
April 7, 2022
April 9, 2021
April 9, 2020
April 17, 2019